131 results on '"Bansal-Travers, Maansi"'
Search Results
2. Exposure to IQOS ads and reduced exposure claims, and association with perceived risk from COVID-19 on IQOS purchase and use intentions: results from a web-based survey
3. Cardiovascular disease outcomes among established cigar users 40 years and older: Findings from the Population Assessment of Tobacco and Health (PATH) Study, Waves 1-5 (2013-2019)
4. Perceived Truthfulness of Reduced Lung Cancer Risk Advertising Claims Influences Consumers’ Intention to try and to Purchase Snus
5. E-Cigarette Marketing Exposure and Subsequent Experimentation Among Youth and Young Adults
6. Perceptions of harmfulness of heated tobacco and nicotine vaping products compared to cigarettes, and the association of advertising exposure on harm perceptions among adults who smoke in South Korea: Cross-sectional findings from the 2020 ITC Korea Survey
7. Differences in demographics and behaviors across two web-based survey platforms: Observations from a study of risk perceptions of heated tobacco products (HTPs)
8. Exploring the psychometric properties of a tripartite model of risk perception (TRIRISK) in a general U.S. population sample
9. Impact of the FDA flavour enforcement policy on flavoured electronic cigarette use behaviour changes
10. Correlates of tobacco product initiation among youth and young adults between waves 1–4 of the population assessment of tobacco and Health (PATH) study (2013–2018)
11. E-cigarette and tobacco product use among NYS youth before and after a state-wide vaping flavour restriction policy, 2020–2021
12. Do Current Smokers and Ex-Smokers Who Use Nicotine Vaping Products Daily Versus Weekly Differ on Their Reasons for Vaping? Findings from the 2020 ITC Four Country Smoking and Vaping Survey
13. Oral Nicotine Product Awareness and Use Among People Who Smoke and Vape in the U.S.
14. Evaluating the Immediate Impact of Graphic Messages for Vaping Prevention among Black and Latino Adolescents: A Randomized Controlled Trial
15. Common Measures to Evaluate Flavored Tobacco Products: Recommendations From the Tobacco Centers for Regulatory Science (TCORS) Flavored Tobacco Products Measurement Subcommittee
16. Adapting Community Educational Programs During the COVID-19 Pandemic: Comparing the Feasibility and Efficacy of a Lung Cancer Screening Educational Intervention by Mode of Delivery
17. Do number of smoking friends and changes over time predict smoking relapse? Findings from the International Tobacco Control Four-Country Survey
18. Intention to purchase alternative tobacco products as a function of smoking status and responses to advertising, packaging, and sensory experiences
19. E-Cigarette Flavors, Devices, and Brands Used by Youths Before and After Partial Flavor Restrictions in the United States: Canada, England, and the United States, 2017‒2020
20. Factors associated with changes in flavored tobacco products used: Findings from wave 2 and wave 3 (2014–2016) of the population assessment of tobacco and health (PATH) study
21. Noticing people, discounts and non-tobacco flavours in e-cigarette ads may increase e-cigarette product appeal among non-tobacco-using young adults
22. Predictors of E-cigarette and Cigarette Use Trajectory Classes from Early Adolescence to Emerging Adulthood Across Four Years (2013–2017) of the PATH Study
23. Cardiovascular disease outcomes among established cigar users 40 years and older: Findings from the Population Assessment of Tobacco and Health (PATH) Study, Waves 1- 5 (2013-2019)
24. Exposure to Negative News Stories About Vaping, and Harm Perceptions of Vaping, Among Youth in England, Canada, and the United States Before and After the Outbreak of E-cigarette or Vaping-Associated Lung Injury (‘EVALI’)
25. Do Smokers’ Perceptions of the Harmfulness of Nicotine Replacement Therapy and Nicotine Vaping Products as Compared to Cigarettes Influence Their Use as an Aid for Smoking Cessation? Findings from the ITC Four Country Smoking and Vaping Surveys
26. Cardiovascular Outcomes among Combustible-Tobacco and Electronic Nicotine Delivery System (ENDS) Users in Waves 1 through 5 of the Population Assessment of Tobacco and Health (PATH) Study, 2013–2019
27. Differences in Demographics and Behaviors Across Two Web-Based Survey Platforms: Observations from a Study of Risk Perceptions of Heated Tobacco Products (HTPs)
28. Developing Graphic Messages for Vaping Prevention Among Black and Latino Adolescents: Participatory Research Approach
29. Smokeless Tobacco Use and Prevalence of Cardiovascular Disease Among Males in the Population Assessment of Tobacco and Health (PATH) Study, Waves 1-4
30. Home Tobacco Use Policies and Exposure to Secondhand Tobacco Smoke: Findings from Waves 1 through 4 of the Population Assessment of Tobacco and Health (PATH) Study
31. Price promotion receipt and use progression of any tobacco, cigarettes, e-cigarettes and cigars among US youth between 2016 and 2018
32. Electronic cigarette use intensity measurement challenges and regulatory implications
33. Risk Perceptions of Low Nicotine Cigarettes and Alternative Nicotine Products across Priority Smoking Populations
34. Urinary Cotinine and Cotinine + Trans-3′-Hydroxycotinine (TNE-2) Cut-points for Distinguishing Tobacco Use from Nonuse in the United States: PATH Study (2013–2014)
35. Characteristics and changes over time of nicotine vaping products used by vapers in the 2016 and 2018 ITC Four Country Smoking and Vaping Surveys
36. Smokers’ perceptions of different classes of cigarette brand descriptors
37. Indicators of dependence and efforts to quit vaping and smoking among youth in Canada, England and the USA
38. Impact of Cigarette Filter Ventilation on U.S. Smokers' Perceptions and Biomarkers of Exposure and Potential Harm
39. Association of Electronic Nicotine Delivery System Use With Cigarette Smoking Progression or Reduction Among Young Adults
40. Menthol and Mint Cigarettes and Cigars: Initiation and Progression in Youth, Young Adults and Adults in Waves 1–4 of the PATH Study, 2013–2017
41. Transitions in frequency of hookah smoking among youth and adults: findings from waves 1 and 2 of the Population Assessment of Tobacco and Health (PATH) study, 2013–15
42. Home smoking and vaping policies among US adults: results from the Population Assessment of Tobacco and Health (PATH) study, wave 3
43. Role of e-cigarettes and pharmacotherapy during attempts to quit cigarette smoking: The PATH Study 2013-16
44. Adult perceptions of the relative harm of tobacco products and subsequent tobacco product use: Longitudinal findings from waves 1 and 2 of the population assessment of tobacco and health (PATH) study
45. Menthol, Nicotine, and Flavoring Content of Capsule Cigarettes in the US
46. Smokers Awareness and Risk Perceptions of Filter Ventilation
47. Impact of menthol delivery methods on smoker sensory perceptions
48. Correlates of tobacco product reuptake and relapse among youth and adults in the USA: findings from the PATH Study Waves 1–3 (2013–2016)
49. Overview of tobacco use transitions for population health
50. Longitudinal pathways of exclusive and polytobacco smokeless use among youth, young adults and adults in the USA: findings from the PATH Study Waves 1–3 (2013–2016)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.